Skip to content
10-Q

Quarterly Report

MEDICUS PHARMA LTD. MDCX MDCXW

0001062993-25-016838

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 22.03M sh
Shares Diluted Q3 2025 · Sep 30, 2025 18.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.84M sh
Shares Diluted Q3 2025 · Sep 30, 2024 9.51M sh
Shares Diluted Q3 2025 · Sep 30, 2024 9.04M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$16.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$7.06M
Short Term Debt Q3 2025 · Sep 30, 2025 $6.79M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $8.66M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.16M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$910.13K
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.13M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.66M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.31M
Total Liabilities Q3 2025 · Sep 30, 2025 $10.78M
Total Liabilities Q3 2025 · Dec 31, 2024 $2.51M
Current Assets Q3 2025 · Sep 30, 2025 $9.78M
Current Assets Q3 2025 · Dec 31, 2024 $5.38M
Total Assets Q3 2025 · Sep 30, 2025 $9.98M
Total Assets Q3 2025 · Dec 31, 2024 $5.65M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.12
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.91
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.24
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.84
Eps Basic Q3 2025 · Sep 30, 2025 −$1.12
Eps Basic Q3 2025 · Sep 30, 2025 −$1.91
Eps Basic Q3 2025 · Sep 30, 2024 −$0.24
Eps Basic Q3 2025 · Sep 30, 2024 −$0.84
Sga Expense Q3 2025 · Sep 30, 2025 $5
Sga Expense Q3 2025 · Sep 30, 2025 $12.72M
Sga Expense Q3 2025 · Sep 30, 2024 $1.77M
Sga Expense Q3 2025 · Sep 30, 2024 $5.43M
Rd Expense Q3 2025 · Sep 30, 2025 $1.68M
Rd Expense Q3 2025 · Sep 30, 2025 $5.13M
Rd Expense Q3 2025 · Sep 30, 2024 $564.15K
Rd Expense Q3 2025 · Sep 30, 2024 $2.16M
Net Income Q3 2025 · Sep 30, 2025 −$20.94M
Net Income Q3 2025 · Sep 30, 2025 −$32.21M
Net Income Q3 2025 · Sep 30, 2024 −$2.28M
Net Income Q3 2025 · Sep 30, 2024 −$7.62M
Operating Income Q3 2025 · Sep 30, 2025 −$15
Operating Income Q3 2025 · Sep 30, 2025 −$26.57M
Operating Income Q3 2025 · Sep 30, 2024 −$2.33M
Operating Income Q3 2025 · Sep 30, 2024 −$7.6M